HomepageMedicineMaking the Leap from Pharmaceuticals to Private Equity, Venture Capital Medicine Making the Leap from Pharmaceuticals to Private Equity, Venture Capital admin Posted on September 12, 2024 A Harvard Business School Healthcare Alumni Association Q&A with Jeremy Goldberg of Arsenal Capital Partners. LEAVE A RESPONSE Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. admin View all posts Post navigation Previous PostMicrosoft acquires 16.4-acre land in Pune for ₹520 crore Next PostWhat People Wore During New York Fashion Week You Might Also Like Medicine The Impact of Artificial Intelligence on the Creation of Medicines admin October 25, 2024 Medicine FDA Grants Priority Review to Mirdametinib for Neurofibromatosis Type 1-Associated Plexiform Neurofibromas admin August 30, 2024 Medicine Gilead, Xilio Therapeutics Ink Exclusive Licensing Agreement to Develop Early Phase Tumor-Activated IL-12 admin March 31, 2024 Medicine Amylyx Pharmaceuticals Acquires Phase III-Ready GLP-1 Receptor Agonist Avexitide for Hyperinsulinemic Hypoglycemia from Eiger BioPharmaceuticals admin July 13, 2024
Medicine FDA Grants Priority Review to Mirdametinib for Neurofibromatosis Type 1-Associated Plexiform Neurofibromas admin August 30, 2024
Medicine Gilead, Xilio Therapeutics Ink Exclusive Licensing Agreement to Develop Early Phase Tumor-Activated IL-12 admin March 31, 2024
Medicine Amylyx Pharmaceuticals Acquires Phase III-Ready GLP-1 Receptor Agonist Avexitide for Hyperinsulinemic Hypoglycemia from Eiger BioPharmaceuticals admin July 13, 2024